Gene therapy trial partially restores eyesight

Gene therapy trial partially restores eyesight
The full potential of the new therapy to cure blindness has yet to be realised. Keystone / Binsar Bakkara
A blind man has regained part of his sight after a new treatment genetically engineered his eye to produce light-sensitive algae proteins.
This content was published on May 25, 2021 - 11:32
May 25, 2021 - 11:32
swissinfo.ch/mga
The technique, known as optogenetics, was successfully trialled in France with input from the Institute of Molecular and Clinical Ophthalmology Basel (IOB), which is affiliated with the University of Basel.  
Cells in the man’s retina were programmed to produce a protein called ChrimsonR, which is sensitive to light. The protein is naturally produced by algae to help them detect light.

Related Keywords

Paris ,France General ,France ,Gensight Biologics ,Botond Roskaexternal ,Institute Of Vision ,Institute Of Molecular ,University Of Pittsburgh ,University Of Basel ,University Hospital Basel ,Novartis ,Clinical Ophthalmology Basel ,Nature Medicineexternal ,பாரிஸ் ,பிரான்ஸ் ஜநரல் ,பிரான்ஸ் ,நிறுவனம் ஆஃப் பார்வை ,நிறுவனம் ஆஃப் மூலக்கூறு ,பல்கலைக்கழகம் ஆஃப் பிட்ஸ்பர்க் ,பல்கலைக்கழகம் ஆஃப் பேசல் ,பல்கலைக்கழகம் மருத்துவமனை பேசல் ,நோவர்த்திச் ,மருத்துவ கண் மருத்துவம் பேசல் ,